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Making large-scale surgical trials possible:
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Abstract
Background: Recruitment to surgical randomised controlled trials (RCTs) can be challenging. The Sunflower study
is a large-scale multi-centre RCT that seeks to establish the clinical and cost effectiveness of pre-operative imaging
versus expectant management in patients with symptomatic gallstones undergoing laparoscopic cholecystectomy
at low or moderate risk of common bile duct stones. Trials such as Sunflower, with a large recruitment target, rely
on teamworking. Recruitment can be optimised by embedding a QuinteT Recruitment Intervention (QRI).
Additionally, engaging surgical trainees can contribute to successful recruitment, and the NIHR Associate Principal
Investigator (API) scheme provides a framework to acknowledge their contributions.
Methods: This was a mixed-methods study that formed a component part of an embedded QRI for the Sunflower
RCT. The aim of this study was to understand factors that supported and hindered the participation of surgical
trainees in a large-scale RCT and their participation in the API scheme. It comprised semi-structured telephone
interviews with consultant surgeons and surgical trainees involved in screening and recruitment of patients, and
descriptive analysis of screening and recruitment data. Interviews were analysed thematically to explore the
perspectives of—and roles undertaken by—surgical trainees.
Results: Interviews were undertaken with 34 clinicians (17 consultant surgeons, 17 surgical trainees) from 22 UK
hospital trusts. Surgical trainees contributed to patient screening, approaches and randomisation, with a major
contribution to the randomisation of patients from acute admissions. They were often encouraged to participate in
the study by their centre principal investigator, and career development was a typical motivating factor for their
participation in the study. The study was registered with the API scheme, and a majority of the trainees interviewed
(n = 14) were participating in the scheme.
Conclusion: Surgical trainees can contribute substantial activity to a large-scale multi-centre RCT. Benefits of trainee
engagement were identified for trainees themselves, for local sites and for the study as a whole. The API scheme
provided a formal framework to acknowledge engagement. Ensuring that training and support for trainees are
provided by the trial team is key to optimise success for all stakeholders.
Keywords: Qualitative research, Optimising RCT recruitment, Trainees, Trial conduct and management, Associate PI
scheme
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Background
Clinical decision-making is ideally based on the best
available evidence [1] from well-conducted and designed
randomised controlled trials (RCTs). For patients with
symptomatic gallbladder disease being offered laparo-
scopic cholecystectomy (LC), there is currently a lack of
evidence for how to optimally assess the risks of com-
mon bile duct (CBD) stones before surgery. Although as-
sessment typically uses a combination of liver function
tests (LFTs) and imaging (ultrasound scan (USS) plus or
minus magnetic resonance cholangiopancreatography
(MRCP)), the clinical benefit and cost effectiveness of
undertaking pre-operative imaging for all patients to ex-
plore for the presence of CBD stones is unclear, al-
though for patients classified as high risk of stones
imaging is generally recommended [2, 3]. This is import-
ant because in England alone some 70,000 LCs are
undertaken. The Sunflower study [HTA project refer-
ence: 16/142/04] [4] is a UK-based multi-centre, prag-
matic, unblinded RCT which aims to establish the
clinical and cost effectiveness of pre-operative imaging
with MRCP versus expectant management (i.e. no pre-
operative imaging) in patients with symptomatic gall-
stones undergoing LC at low or moderate risk of CBD
stones.
The Sunflower RCT has an ambitious recruitment tar-
get: 13,680 patients randomised to the study in 4 years,
from at least 50 UK NHS hospital trusts. To increase the
generalisability of the study findings, the sample will in-
clude patients who are scheduled for LC as either an
elective or urgent procedure. For elective LC patients, it
is likely that they will be approached at consultant-led
outpatient clinics, with support from trainees and re-
search nurse teams. Urgent admissions may be admitted
at any time of the day, including at times when the routine
research support infrastructure may not be available.
Thus, at the point of trial design, the Sunflower investiga-
tors designed the study to include a QRI and administra-
tive support to actively engage surgical trainees using the
API scheme. There was a dual purpose: to optimise pa-
tient recruitment in the acute setting and to invest in
trainees’ research experience to develop capacity. We
hoped to create a future group of surgeons who under-
stand and can participate in trials so that they deliver
evidence-based practice. In the UK, the National Trainee
Research Collaboratives (NTRC) have previously led
multi-centre surgical research studies including cohort
studies [5–7] as well as RCTs [8–10]. These studies dem-
onstrate the motivation of trainees to take part in research
alongside their clinical training [11], in particular where
they play a lead role in the study design and implementa-
tion. In RCTs with an emergency context, trainees may be
more readily available to consent patients, although may
benefit from support to do so [12]. Less well reported are
studies where trainees have played a parallel role alongside
consultant surgeons. Initiatives to encourage trainees to
become research active clinicians include the National In-
stitute for Health Research (NIHR) Associate PI (API)
scheme. The API scheme was introduced in April 2019,
with aims to develop junior doctors, nurses or allied
health professionals to be Principal Investigators (PIs) of
the future by encouraging and recognising their engage-
ment in NIHR portfolio research [13]. Little is known
about how this scheme is working in the context of open
trials. The Sunflower study is registered to the API
scheme.
The overall aim of this study was to understand factors
that supported and hindered the participation of surgical
trainees in a large-scale RCT and their participation in
the API scheme. We sought to do this by exploring the
specific roles undertaken by surgical trainees in the Sun-
flower study. Additionally, we drew on interviews with
consultant surgeons, who, in the context of Sunflower,
provide a mentoring role to trainees, to understand what
they consider to be the contributions of trainees. We




The Sunflower study is a randomised trial that seeks to
explore the pre-operative management of patients with
symptomatic gallstones. Patients are randomised either
to the intervention: a pre-operative magnetic resonance
cholangio-pancreaticogram (MRCP) followed by laparo-
scopic cholecystectomy (LC) surgery or to expectant
management (EM) (patients are listed for LC without
pre-operative MRCP). Patients are randomised to MRCP
or EM in a 1:2 ratio.
The primary outcome of the Sunflower study is any
hospital admission within 18 months of randomisation
for a complication of gallstones. The study’s first centre
opened to recruitment in January 2019. Recruitment
paused on 20 March 2020 because of the COVID-19
pandemic. At the time of closing, 48 UK centres were
open to recruitment and 1990 patients had been rando-
mised. The pause ended in August 2020, and by 4 January
2021, 2229 patients had been randomised. Recruitment at
each centre was led by a site PI (typically a consultant sur-
geon), with support from surgical trainees, radiologists
and research nurses. The study included an embedded
QuinteT Recruitment Intervention (QRI). The QRI is a
well-established intervention [14] that aims to support
challenging RCTs to optimise recruitment and informed
consent through a combination of methods, including in-
terviews with RCT recruiting staff. We conducted this ex-
ploratory qualitative study, as part of the Sunflower study
QRI; additionally, a 50% FTE study trainee administrator
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was employed to support the trainee involvement and
engagement.
Sampling strategy
The population for the qualitative element of this study
was surgical trainees and consultant surgeons registered
on the delegation log for the Sunflower study either as
site lead trainee or as site PI. Respondents were
approached for an interview once their centre had been
open to recruitment for 3 months, to give them time to
become familiar with the implementation of the study at
their centre. The initial approach for the interview was
made by the senior study administrator by email, and in
cases where there was no response, with at least one fur-
ther follow-up email. Interviewees were sent a study in-
formation leaflet and completed a consent form prior to
their interview, or immediately after, having given verbal
consent at the start of the recording. Interviews pro-
ceeded up to the point when the study was suspended to
recruitment in response to the COVID-19 pandemic in
March 2020, then continued as sites re-opened in Au-
gust 2020.
Data collection
All interviews were undertaken by a male, non-clinically
trained, experienced qualitative researcher (MJ). A semi-
structured interview topic guide was developed on the
basis of the researcher’s experience on other RCTs [15,
16] and in discussion with two clinically trained co-
authors (NB and SP). The topic guide included open
questions about each respondent’s experience of RCTs
and research generally and their specific experience on
the Sunflower study. The trainee topic guide additionally
included questions about their experiences and opinions
on the API scheme. Although the topic guide provided a
framework on which to base the interviews, it was not
followed rigidly, and should the discussion evolve, or
take different directions, this was permitted. Hence,
whilst the topic guide was piloted with one interviewee,
it was not amended over the course of the study.
All interviews were conducted over the telephone, at a
time suited to the respondent. All were audio recorded
using encrypted digital recorders and then transcribed
verbatim with personal identifiers removed. Screening
and recruitment activity, showing admission type (elect-
ive or acute), and job role of the person undertaking the
assessment of patient eligibility, approach and consent-
seeking (consultant, trainee or research nurse) were rou-
tinely recorded by study sites and collated centrally on
the study database.
Data analysis
Qualitative data analysis began after the first five inter-
views were completed and was repeated during the
study. Transcripts were checked against recordings for
accuracy by MJ and then uploaded to Nvivo 12 [17] for
coding. They were not shared with interviewees. Our
analytic approach was inductive. Transcripts were ana-
lysed using constant comparison methods, with new data
compared with earlier examples. Initially, transcripts
were coded by MJ against the sections of the interview
topic guides. This coding framework was developed it-
eratively with further themes and codes added during
analysis to ensure details not captured in the original
frame were not missed. Two additional interviews
undertaken after the study re-opened following the
pandemic-enforced shutdown did not generate any new
codes or data, thus indicating that a notional data satur-
ation had been achieved [18]. MJ wrote descriptive defi-
nitions of the themes. These were shared, discussed and
agreed with other authors (NB, SP, JC, MC) with expert-
ise in the clinical (as consultant and surgical trainee) and
trial management aspects of the study question. Num-
bers and percentages of patients consented by discipline
and according to admission type and screening log activ-
ity by discipline were extracted from the study database
by ML on 4 January 2021.
Results
Participant demographics
Interview invitations were sent to 29 surgical trainees
and 30 consultant surgeons at sites that had been open
to recruitment for more than 3 months (one site did not
have a named lead surgical trainee at the time). Of those
approached, 9 declined (4 trainees; 5 consultants) and 16
(8 trainees; 8 consultants) did not respond to the initial
request or to two follow-up requests. Invitations were
sent once the respective centre had been open to re-
cruitment for at least 3 months, to ensure respondents
had the experience of recruiting patients. A total of 34
interviews from 22 recruiting centres were undertaken
with 17 surgical trainees (6 female; 11 male) and 17 con-
sultant surgeons (2 female; 15 male) between January
2019 and August 2020. The average interview duration
was 25 min (range 15–43 min). Consultant surgeons had
been qualified for between 16 and 31 years (mean 22
years). Surgical trainees had been qualified for between 7
and 16 years (mean 11 years).
Four key areas of analytic interest were identified in
the data: how trainees became involved in the Sunflower
study, trainees’ experiences of engagement with the API
scheme, descriptions of the trainees’ roles on the Sun-
flower study and the benefits trainees derived from study
participation.
How trainees became involved in the Sunflower study
Respondents described how they came to be involved in
the Sunflower study. It was rare for trainees to initiate
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their involvement, and typically, the initiative to take
part came about as a result of being put forward or en-
couraged by the consultant PI at their site. Most com-
monly, this was driven by the PI recognising a need for
support with study recruitment:
[PI name] sent round an email to everyone saying
we’re doing this, does anyone want to get involved
to help with recruitment? [Trainee 9]
In most cases, trainees interviewed would only expect
to be in their current hospital for a maximum of 12
months, although there were circumstances where
trainees had a longer rotation. In these cases, this trainee
had been asked to take a lead role in the study because
of their longer tenure, such as Trainee 5, who expected
to remain at the same site for a full year:
[PI name] … asked me if I’d be interested, because
I’m going to be there for a while, it’s good for kind
of consistency [Trainee 5]
The stated motivating factors for encouraging trainees
to take part in Sunflower sometimes went beyond simply
supporting study recruitment. In some cases, the site PIs
demonstrated a strong belief in a culture of research and
had provided encouragement to their trainees to partici-
pate as part of their career development. For example,
this PI described how they were trying to make a cul-
tural change in their Trust:
I’m a massive advocate for trainees being involved
in research and certainly, you know, basically every
time I’m operating with a new trainee I talk to them
– have you got GCP, you want to get involved in
these studies. Obviously, I don’t try to completely
force people into – just trying to shift the culture. I
still look at the lists – ST3 and ST1 regional teach-
ing things about options of getting involved in re-
search including things like Sunflower. To try and
promote getting people involved. [Consultant 15]
Engagement with the API scheme
In order to complete the API scheme, participants must
have been a member of the site research team for a
minimum of 6 months. They must complete an online
learning course and record evidence of their participa-
tion in the RCT on the API scheme status checklist (see
the Appendix) against core (mandatory) and additional
(non-mandatory) activities, which is checked and
authorised by the local PI and the Trial manager. Core
activities are categorised as team activities (through be-
ing named on the study delegation log; disseminating
the study at the local site; meeting regularly with the PI
and local study team; supporting the PI and attending
local research meetings), study management/compliance
activities (checking screening logs) and patient-related
activities (being involved in consenting patients to the
RCT). Additional activities include interacting with the
clinical trial unit, standing in for the PI at study meet-
ings, collaborating with other APIs and involvement in
PPI activities.
At the time this paper was written, 34 trainees, from
30 Sunflower centres, had engaged with the API scheme
in some form. In some cases, this simply involved them
approaching the trainee administrator to ask for infor-
mation about the scheme in relation to the Sunflower
study:
I’ve signed up for it officially but I haven’t, I haven’t
been through the paperwork with ((PI name)).
That’s something I need to do in due course. And
the one thing I’ve struggled with, and I think that’s
my fault more than anything [Trainee 6]
Contrastingly, others talked about completing some,
or all of the relevant documentation to achieve certified
API status.
I’ve done all the things properly - I haven’t actually
put my - I didn’t put my NIHR paperwork in …. So
broadly speaking yes, I’ve been, sort of, delegated
the roles but I haven’t got the official - I haven’t
done the official NIHR paperwork. [Trainee 7]
Motivations for participating in the API scheme were
dominated by the perceived career benefit it would
bring:
Interviewer: What was your motivation for signing
up for the scheme?
Trainee 3: I read up on it and saw that it would be
good because you will be recognised, it would be an
extra recognition of my work. Nowadays for our
CVs it’s quite important to have evidence … that
you’ve done something … and you’ve taken part in
the study.
so I’m coming to the end of my training and hope
to become a consultant soon, …it’s [the API role]
something I’m definitely hoping to talk about at the
interview. … I think the associate PI scheme has
really encouraged me to feel a part of the team
[Trainee 6]
In another case, whilst their professional role had not
changed, this interviewee appreciated the status associ-
ated with having the title of API:
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Having the title, I think the role that I play would
probably not have been too different without a title.
But having a title I think recognises you that you’re
doing this job specifically [Trainee 10]
The same respondent also suggested that having a
‘named’ API could benefit the study also, by providing a
more available contact point than, for example, a con-
sultant PI:
It’s also useful as a person as a contact to go to…. I
think people locally who know that the Trainee PI
is out there and probably more approachable and
probably more free with my time there than the
consultant PI might be [Trainee 10]
In one case, participation for a more experienced
trainee had been driven by an interest in the research
generally and the research question in the study
specifically:
does (the API Scheme) affect me going forward in
terms of my CV? I don’t think it really makes a huge
amount of difference. I do think being involved in
these studies and being actively involved over a
period of time makes a difference. And I actually
believe in the studies as, sort of, corny as that
sounds. I actually quite like research and I like this
study, I think it’s a really good study. So I wasn’t
hugely drawn in by the title or the role but was
happy to take it on to try and drive the study.
[Trainee 7]
Of those interviewed, only one had made a conscious
decision to not join the API scheme; that trainee did not
see how they would benefit from it:
I don’t see what it would add to my (career)… my
role wouldn’t change that much considering that
I’m the trainee lead here even if I did the associate
PI scheme. I don’t understand how because ((Con-
sultant)) would still be leading it. [Trainee 1]
Trainees’ contributions to the study
From the outset of the study, it was expected that surgi-
cal trainees’ main contribution to the study would be
through the recruitment of patients in emergency con-
texts. This expectation was confirmed by PIs and
trainees alike:
So, when [trainee name] is on call he can look after
the emergency admissions, and pick up patients
through that [Consultant 1]
… (the trainees) are mainly picking up emergency
ones, so they’re helping on that front. [Consultant 16]
Essentially [my role is] … particularly finding acute
patients whenever I was on call … highlighting that
these patients for example were suitable for the
study, highlighting that to the consultant… And
then recruiting for the study [Trainee 3]
However, surgical trainees also provided support to
outpatient elective clinics, either shadowing consultants
or leading the study in those contexts:
[Trainee] works with the other two consultants as
well and does their clinics, so I’m hoping that
[trainee] will start recruiting their patients and that
might feed upwards to the other consultants [Con-
sultant 6]
Screening log data showed the proportion of patients
consented to the study by surgical trainees was propor-
tionally higher in acute admissions (Table 1).
In addition to consenting patients to be randomised to
the study, trainee roles also included screening hospital
lists, assessing patients against the study inclusion cri-
teria and completing study paperwork—for example,
screening logs and entering data onto the study data-
base. One trainee described his involvement in the study
and his liaison with others:
I’m going through the inclusion criteria in clinic, …
[consultant name] will actually go through his clinic
list in advance too and help identify potential re-
cruits, then we’ve got a very good research nurse
who is very heavily involved, and sometimes she’ll
come down to the clinic to give a hand as well…
And once we’ve identified [an eligible patient] we’ll
usually broach the subject and just explain a bit
about the role of MRCP and then explain that it’s
uncertain whether it adds any clinical benefit for pa-
tients who’ve got normal or normal-ish liver func-
tion tests and whether they have to take part in a
study to identify whether it is of benefit to help
themselves and future patients. [Trainee 5]
This collaborative approach was common among the
sample. A consultant PI described how another trainee
had been working with the team in their trust on the study
who wanted to develop their role to also screen lists of pa-
tients as well as approaching them in the clinic:
I’ve got (trainee name) who’s our trainee lead for
this. And I’ve had another registrar who has actively
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recruited the patients, and she’d rung me up and
said come and show me how to do this because I
need a hand, but she’s been very competent as well.
So, that’s all been good [Consultant 10]
The study database recorded who had undertaken four
stages of activity, which included (i) identifying patients
(screened), (ii) providing study information (provided
PIL), (iii) having initial discussions (approached), through
to (iv) receiving their consent (consented) (Table 2). The
highest level of activity entered on the database was by re-
search nurses or practitioners. As can be seen in Table 2,
trainee and consultant activity levels were very similar,
with trainees screening more patients than consultants
(17% of all v 11%). These quantitative data support the ex-
periences described in the qualitative interviews. It should
be noted that not all activities were undertaken by the
same person. For example, it is plausible that a patient
could be screened by a trainee, provided with a PIL by a
research nurse, approached by a consultant and consented
and randomised by a research nurse.
Benefits that trainees derived from study participation
In addition to the benefits of participating in the API
scheme, trainees also reported a range of benefits from
being involved in the Sunflower RCT. These were most
commonly in relation to their career development. For
example, they envisaged that they would be able to
document RCT involvement on their CV—including
completion of Good Clinical Practice (GCP) training—
and this would benefit their career aspirations as ‘re-
search active clinicians’ and potentially to become a
centre PI in their own right.
I think it [taking part in Sunflower] certainly would
look good on the CV and also gear me up to getting
more involved in research in the future, exploring
these options of ways to expand my career
[Trainee 5]
Consultant surgeons also identified career benefits for
their trainees. For example, some stated that RCT par-
ticipation would contribute to the trainees’ ability to
enter the Specialist Register through completion of their
Certificate Completion of Training (CCT):
Because basically for trainees it used to be that you
had to write three papers to get the CCT, but now
you just have to show evidence of collaboration in
research and recruiting patients does count. [Con-
sultant 4]
ultimately, it’s about learning and training and say-
ing you’ve recruited to studies … actually being able
to say, “I have screened people for an RCT, I’ve con-
sented them, I did the training to do that,” is now
considered a much more important skills in terms
of your training and the criteria you need to meet
to progress within the different training pro-
grammes [Consultant 17]
In other instances, particularly for those who intended
to pursue a clinical specialism in hepatobiliary or upper
GI surgery, trainees were invested in the outcome of the
Sunflower study. Thus, by contributing to the study’s re-
cruitment, they saw themselves as helping to inform
clinical practice, either in general or specifically in their
intended clinical specialty:
I think there’s a lot of inefficiency in the NHS and
so this is something that provides clear black and
Table 1 Screening log consent by discipline and admission type (data extracted 4 January 2021)
Elective (of 1665 patients) Acute (of 504 patients)
N % n %
Consultant 291 17% 89 18%
Trainee 185 11% 176 35%
Res nurse/practitioner 1189 71% 239 47%
Admission type data was not available for all patients, hence a discrepancy of 60 patients between totals consented in Tables 1 and 2









N % N % N % N %
Consultant 525 11% 504 16% 483 17% 394 18%
Trainee 758 17% 401 13% 441 15% 375 17%
Res nurse/others 3242 72% 2173 71% 1940 68% 1460 65%
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white answers to – sometimes what seems like inef-
ficiency. [Trainee 13]
I mean, if we manage to find out that a significant,
or a proportion of the MRCPs that we organise are
not useful, you know, that’s a big achievement I
think. [Trainee 12]
it’s a clinically incredibly important [research] ques-
tion and relevant and so that’s what I like about the
study. It has potential to really change practice, ei-
ther way. You know, it could really show, could
really show that an MRCP is a really important
safety feature of the way we manage these patients.
It’s really important to know that [Trainee 7]
Discussion
This paper has explored how surgical trainees have been in-
tegrated into the NIHR Sunflower study and the NIHR API
scheme. It aims to understand factors that supported the
participation of surgical trainees in a large-scale RCT and
their participation in the API scheme. We developed sev-
eral themes from our qualitative analysis of interviews with
34 clinicians (consultant and trainee surgeons) which were
that trainees typically became involved in the Sunflower
study as a consequence of being encouraged to do so by
the consultant lead at their local site or through prompting
from the study trainee administrator. Many of the trainees
interviewed (14 of 17) had engaged with the NIHR API
scheme as part of their role on the Sunflower study, citing
the potential benefit to their career development. Trainees
had been involved in all phases of recruitment to the study:
screening clinic lists, assessing for eligibility against the
study inclusion and exclusion criteria, approaching patients
and seeking their consent to be randomised. Trainee’s con-
tribution to the study had taken place in both elective and
acute settings. From the beginning of the study to January
2021, 35% of all acute patients (n = 185) and 11% of elective
patients (n = 175) were consented to the study by a trainee.
We may deduce from these figures that recruitment to the
study would have been significantly lower without these
substantial contributions, in particular in acute settings. As
well as gaining career benefits from participation in the
Sunflower study, those with an HPB or upper GI specialty
were invested in contributing to a study with the potential
to change clinical practice in their discipline. Embedding
the API scheme into a large-scale RCT to optimise recruit-
ment and invest in future research capacity is therefore rec-
ommended as a useful contribution.
The success of multi-site RCTs relies on the engage-
ment of local research teams [19] and, in common with
our findings, the role of a consultant champion has been
considered valuable to support trainees’ engagement in
RCTs [20]. The role of consultant-as-mentor can have a
positive benefit on trainees’ career development, particu-
larly where the consultant shows an ‘investment’ in the
trainee [21]. In Sunflower, a number of consultants dem-
onstrated that they were considering their trainee col-
league’s future plans, pinpointing the types of research
skills needed to aid their progression. In Sunflower, add-
itional resources were allocated to enable trainee en-
gagement. Prior to each site initiation, the study trainee
administrator emailed the site PI to encourage them to
identify a trainee who may act as lead for their centre.
Additionally, at site initiation meetings, the potential
benefit to the RCT of having trainee collaboration was
outlined, in particular their recognition on study publi-
cations. Whilst we acknowledge as a limitation that we
did not explore in detail trainees’ views on the role of
the trainee administrator, we suggest that the designated
central administrative support for trainee collaborations,
in addition to core trial management, contributed to the
successful engagement of trainees in the study. The ad-
ministrator tracked trainees as they rotated between
sites, providing advantages for the study: trainees en-
sured continuity by taking their experience to their new
site, and for the trainee: their involvement in the study
could last longer and thus provide further opportunities
to rejoin the API scheme and acquire RCT-related skills.
The Sunflower RCT had more trainees registered with
the API scheme than any other study in the UK at the
time of this study (although subsequently, co-authors
NB and JMB have introduced the API Scheme into the
COVID RECOVERY trial with a higher number of APIs
involved). The majority of those interviewed were par-
ticipating in the scheme, although some had yet to
complete the requisite tasks or paperwork to achieve
completion of the scheme. Career development was the
most commonly cited reason trainees gave for engaging
with the API scheme. Completing the scheme’s paper-
work was seen by some as being burdensome. In a con-
text where surgical trainees report finding work-life
balance challenging [22], this may be off putting to
some. The study’s trainee administrative support helped
to reduce the burden on trainees in relation to the API
scheme. Providing administrative support is recognised
as a key component of good trial conduct generally [23],
we reflect that the additional and specific administrative
support in place to co-ordinate the API scheme, and the
involvement of trainees more widely, was something that
may help other, large-scale studies, to successfully en-
gage with surgical trainees and thus enhance recruit-
ment potential.
Trainees reported that they had undertaken a range of ac-
tivities on the Sunflower RCT. This included screening
clinic lists, assessing patients’ eligibility against the study
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inclusion criteria, discussing the study with them and log-
ging these activities on the study database. In the RCT set-
up phase, case report forms (CRFs) were designed with ref-
erence to the SEAR framework [24]. This recommends
documenting different activities (numbers of patients
screened, eligible, approached and randomised) as a means
of closely monitoring RCT activity, in order to identify any
recruitment obstacles. Research nurses had apparently
undertaken the majority of each logged study activity
(screening, providing PILs, approaching and consenting pa-
tients). Anecdotal evidence from informal discussions with
a sub-set of research nurses suggested that this may, in part,
have been a result of their role transferring case report
forms (CRFs) onto the study database, a role commonly
undertaken by clinical research nurses [25]. What the data
clearly evidence is that the logged contribution of trainees
and consultants in each of those four areas was almost
identical. When we compared activity for elective and acute
patients, we observed a marked difference in activity levels.
Trainee surgeons consented a substantially higher propor-
tion of the 504 acute patients, than those consented by con-
sultant surgeons (35% v 18%). Trainees have contributed to
cohort studies, involving acute and elective patients [26].
This paper demonstrates their contributions to recruitment
in an RCT in a similar context.
Analysis of the qualitative data illustrates the recipro-
cal benefits derived by the trainees on this RCT. Being
part of a large-scale national RCT would reflect well for
the participants’ career development. A modified Delphi
study [27] identified two core and four additional re-
quirements of academic achievement for surgical
trainees to gain their certificate of completion of training
(CCT). Active trainee participation in the Sunflower
study would result in trainees meeting at least one core
requirement (undertaking GCP training) and one add-
itional requirement (recruiting patients to a multi-centre
study). The application of the SEAR framework [24] (de-
scribed above) allowed a means of quantifying recruit-
ment and related activities by trainees and other staff.
Recording activity levels such as this can assist with en-
abling a fair collaborative authorship model, a challenge
in large-scale multi-centre RCTs [28]. Being part of an
accredited scheme—in this case, the NIHR API award—
was seen to offer a more formal, demonstrable benefit
than simply being involved in the conduct of the RCT
without that recognition. The benefits of developing a
cohort of research-trained and experienced surgical
trainees fit well with a wider investment in evidence-
based surgery [29] and will enhance the potential of a
‘collaborative’ research-focussed surgical workforce [30].
Recruitment to RCTs can be a complex and challenging
process [31] and a teamworking approach, such as that
described here, can help to mitigate some of these chal-
lenges [32].
Strengths and limitations
As far as we are aware, this is the first qualitative study that
has described the involvement and experiences of surgical
trainees involved in recruitment to a national RCT. The re-
spondents were experts by virtue of being either surgical
trainees or consultants involved in supporting trainees. All
participants had recruitment experience on the Sunflower
RCT. We acknowledge that the respondents were all rela-
tively engaged with the study, and the majority of the
trainees, with the API scheme. We may speculate that those
trainee and consultant surgeons who declined participation
in this interview study were less engaged with this
programme. Our recommendation that administrative sup-
port is in place to encourage trainee involvement and en-
gagement inevitably relies on a study having the necessary
infrastructure and funding in place to do so. Trainees inter-
viewed did not report any substantial barriers to participat-
ing in the RCT, or in relation to the API scheme, nor did
they indicate any reluctance to be involved in the study.
We reflect that the sample represented here were those
with an interest in RCTs and this is a limitation. Future
work may usefully explore reasons why trainees do not par-
ticipate in RCTs or the API scheme.
Conclusions
This study makes a useful contribution to our understand-
ing of the motivations that encourage surgical trainees to
take part in a national RCT, the ways in which they become
involved in an RCT and the mechanisms needed to support
them in their role. We conclude that trainees can, and do,
play a key role in supporting the conduct of multi-centre
large-scale RCTs and this role provides benefits on a num-
ber of levels. In the Sunflower study, at a local level, trainees
provided infrastructure to assist consultants and research
nurses in screening, identifying and consenting patients.
This in turn benefitted the RCT as a whole; with more
personnel engaged in study activity, recruitment numbers
and rates were higher. Trainees derived career development
benefits from involvement in a large-scale multi-site RCT,
with the potential to contribute to changing clinical prac-
tice. The NIHR API scheme provides trainees with a forma-
lised, nationally recognised framework to gain research
skills and demonstrate their engagement with an RCT. As
the API scheme is a relatively new initiative, further re-
search may be useful to monitor how it is integrated into
practice. At present, the scheme is being extended from
surgical trials to all specialities. The NIHR provides central
support and information is available on the NIHR website,
but there are important implications for the trial units that
host trials including API schemes must consider. Future
work is needed in particular to explore any barriers to im-
plementation of the API scheme because of increased ad-
ministrative work for trial units.
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Appendix
Table 3 Consultant gender and specialty
Consultant Gender Specialty Years qualified
1 M General/upper GI 21
2 M General/emergency 19
3 M General/colorectal 31
4 M General/upper GI 19
5 M General/upper GI 18
6 M Upper GI 15
7 M General/upper GI 31
8 F Upper GI 19
9 M Upper GI 20
10 M Upper GI 29
11 M General/upper GI 18
12 M Upper GI 19
13 M Upper GI 24
14 M Upper GI 20
15 F Upper GI 16
16 M General/upper GI 30
17 M HPB 23
Table 4 Trainee gender, grade and specialty
Trainee Gender Role/specialty Grade Years qualified
1 M Upper GI/bariatrics ST5 7
2 F General surgery ST4 11
3 M General surgery ST3 10
4 F Colorectal/all upper GI Staff grade 8
5 M General surgery Trust grade 7
6 M Upper GI ST6 10
7 M Upper GI ST7 10
8 M General surgery ST6 9
9 F Upper GI Staff grade 8
10 M HPB ST5 9
11 M Upper GI ST7 15
12 M Upper GI Post-CCT 14
13 F General surgery CP2 16
14 M HPB ST8 14
15 M CRS ST4 9
16 F General ST4 9
17 F HPB ST8 12
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